IDH2 for Enasidenib (Idhefa)

Alphabetical Test listing

IDH2 for Enasidenib (Idhefa)-994

November 30, 2021

Due to reagent procurement issues and/or staffing shortages at Versiti, the turn-around-time for this assay may be extended.

IDH2 for Enasidenib (Idhefa)
IDH Isocitrate dehydrogenase 2

An aid in identifying acute myeloid leukemia (AML) patients with an (IDH2) mutation for treatment with IDHIFA® (enasidenib).

EDTA whole blood
5.0 mL
1.0 mL

Do not spin; submit entire specimen


Lavender (EDTA), 4mL

EDTA bone marrow
  •  Indicate on specimen tube and requisition whether sample is from whole blood or bone marrow.
  • Versiti requisition form
  • Molecular Medicare billing request
    • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
    • All information requested is required in order for your request to be completed


Versiti Blood Center of WI (7648): R-NX
5 - 7 days

Abbott Realtime IDH2

This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.